What happens when a pharmaceutical research and development (R&D) lab or manufacturing site throws something in the “wrong bin”? It might not seem like a big deal if a half-full solvent bottle or a lithium battery pack gets tossed out with regular trash, but the consequences can be serious.
Misclassifying hazardous waste (or misidentifying pharma waste streams) can lead to regulatory fines, safety incidents, environmental harm, and major headaches for your organization. Beyond penalties, improper waste handling can literally spark disasters. US recycling centers have seen a sharp rise in fires caused by lithium-ion batteries thrown in general waste.
In the pharmaceutical context, an “unknown chemical” bottle found during a lab clean-out is not just a housekeeping issue but a potential explosion or toxic exposure if handled incorrectly. “Waste right” means setting up systems so that every beaker, vial, and battery is correctly identified, labeled, and disposed of in the safest, most compliant way.
Here’s how pharma companies can eliminate misclassification and its risks:
1. Understand the stakes: Why misclassification hurts
It’s easy to underestimate waste rules as mere red tape until a misstep happens. The truth is that misclassified pharma waste can trigger serious consequences. Disposal facilities might reject entire waste shipments if they discover unreported hazardous contents, causing costly returns and emergency handling measures. A mistyped label or unlabeled container in a shipment can put transporters at risk and violate US Department of Transportation (DOT) regulations.
There’s also reputational risk: regulators publicly penalize companies for hazardous waste violations. But beyond compliance, consider safety and environmental impact: misidentifying a reactive chemical as “non-hazardous” could mean it’s mixed with incompatible waste, a recipe for fires or toxic gas release. Improper disposal of active pharmaceutical ingredient (API) waste can lead to contaminating water supplies or soil if not treated correctly. Getting waste classification wrong undermines the very goals of pharma environmental, health, and safety (EHS) practices.
2. Common misclassification pitfalls in pharma: Where do things go wrong?
EHS auditors often see a few recurring issues: unlabeled or “mystery” bottles in labs, misidentification of chemical mixtures, and lack of clear waste segregation. Labs conducting experiments may accumulate unlabeled reagent waste, years later during a clean-out; no one knows what those jars contain. This scenario is all too common and forces expensive testing or hazardous handling.
Another common pitfall is improperly classifying waste. For example, treating all biological waste as strictly biohazardous may overlook chemical hazards, such as ethanol in DNA extraction waste, while misclassifying toxic pharmaceutical waste as regular medical waste can create significant compliance and disposal risks.
Lithium batteries and electronic components are an increasingly important waste and fire safety consideration within pharmaceutical facilities. Batteries used in laboratory equipment, analytical instruments, handheld devices, and facility maintenance tools are often replaced during routine operations, but if improperly discarded, they can create significant fire risks. Used lithium-ion batteries and electronics should be evaluated for proper management as universal waste or hazardous waste rather than being placed in standard trash or dumpsters.
In production plants, misclassifying solvent waste (e.g., failing to recognize a spent solvent mix as ignitable hazardous waste) is another common error. And let’s not forget pharmaceutical product waste: expired compounds might be regulated as hazardous if above certain concentrations, yet personnel sometimes dispose of them as ordinary trash out of ignorance.
Identifying these frequent pitfalls is the first step to fixing them. Conduct a walkthrough of your facility and ask: are all waste containers labeled with contents and start dates? Do we have any “unknowns” sitting around? Are we confident that everyone knows how to dispose of materials that are no longer needed and which wastes are hazardous and which aren’t? Any hesitation in answers signals a gap to address. Do your people know who to ask for help?
3. Implement rigorous waste protocols and training
To “waste right,” pharma companies are adopting more robust waste management systems. Start with clear waste segregation protocols: provide distinct, well-marked containers for different waste streams (e.g., biohazard bins, Resource Conservation and Recovery Act [RCRA] hazardous waste drums, universal waste bins for batteries, e-waste containers) right at the point of generation. Make it easier to do the right thing than the wrong thing.
Next, label everything. Enforce a policy that no bottle or drum goes uncapped or unlabeled for even a few minutes. Many firms use pre-printed color-coded labels (with fields for content, hazard category, date) and place log sheets nearby to record any unknown chemical descriptions before memory fades. Institute a weekly “lab waste review” where lab staff and EHS jointly inspect waste areas, ensuring no unlabeled or improperly stored waste linger, a simple practice that dramatically reduced unknown waste occurrences.
Training is crucial: even experienced scientists and technicians may not know the nuanced waste rules. Conduct targeted training that covers real examples of misclassification errors and how to avoid them. Include housekeeping and facilities staff too since they often handle waste after it leaves the lab. Consider showcasing a past incident (anonymized) where a misclassified waste caused a problem to drive the point home. Regular refreshers should follow whenever regulations change (for instance, the US Environmental Protection Agency’s (EPA) pharmaceutical hazardous waste rule Subpart P requires healthcare and pharma to manage drugs as hazardous waste under specific standards). By building knowledge and clear standard operating procedures (SOPs), you empower employees to make the right call when disposing of anything.
4. Leverage technology for waste tracking
As part of pharma’s digital transformation, EHS teams are turning to software and smart tech to help eliminate waste misclassification. Electronic hazardous waste tracking systems can guide users through proper classification; for example, when someone goes to log a waste pickup request, the system can prompt them with the known hazards of common chemicals or flag if they select an unusual category. Some labs use QR-coded chemical inventory systems: when a container is emptied, scanning its code automatically generates a waste label and classification based on its contents. This reduces human error in labeling and ensures consistent classification plantwide.
Sensors and analytics can help as well. There are smart waste containers that detect if something incompatible has been dropped in (for instance, a sharp pH change indicating someone poured an acid into an alkaline waste drum) and alert EHS staff in real time. While these technologies are still emerging, they illustrate a future where machines and systems can help catch mistakes before they escalate. In the meantime, even using a simple Microsoft Excel-based waste log or an EHS management app can improve visibility.
Track each hazardous waste container from generation to disposal with signoffs creating accountability and chain-of-custody. If a manifest comes back from the disposal company with a discrepancy, you can trace it to the source lab quickly. The goal is to move from ad hoc, memory-reliant processes to data-driven waste management where nothing falls through the cracks.
In pharma EHS, a little extra diligence in waste handling goes a long way. Eliminating misclassification protects people from harm and avoids compliance violations while demonstrating environmental responsibility.
“Waste right” is about doing the right thing every time, ensuring no container is left unidentified and no hazardous material goes to the wrong place.
Meet the author
Susan Wilson, Principal Consultant, BSI
Is your organization confident it’s getting waste management right? Register now for “Better Together: Pharma & Biotech EHS Forum” on June 3, 2026, in Boston, Massachusetts.
